The new security feature is developed by Hyperlink Infosystem, an IT company, helps patients and institutions to detect counterfeits
Zydus Cadila has introduced a new feature in the packaging of its critical drugs to help the patients identify its authentic products from fake or counterfeit ones.
The India-based pharmaceutical company has incorporated a new IT-enabled verification feature, Zydus Verify, where a secret code is printed under a scratchable surface.
Patients can scratch the surface and verify the underlying code through the app or the website, to check whether the product purchased by them is genuine or not.
The new security feature is developed by Hyperlink Infosystem, an IT company focused on software development, IoT, AI and data science, and helps patients and institutions detect counterfeits.
Cadila Healthcare managing director Sharvil Patel said: “The problem of counterfeit drugs undermines the painstaking efforts that are put in to ensure that the end-user or patients receive a product that is safe and manufactured with the highest standards of quality excellence.
“Counterfeit drugs can be harmful as they may not have the desired outcome and could also be life-threatening in some cases.
“To curb this menace we looked at a user-friendly solution which can reassure the patient that the product is genuine and safe. Zydus Verify is a tech-enabled solution that will safeguard patients against counterfeit drugs.”
Zydus said that with increasing cases of counterfeit products in the market, it is necessary to ensure that a 100% genuine product is available to patients.
It will implement the new technology starting with its products Remdesivir and Virafin injection, from the third week of June, with plans to extend to other products.
To use the Zydus Verify feature, patients and institutions are required to download Zydus Verify App from Google Play store and Apple Store or visit the website to enter the code.
The app/webpage connects the code and verifies a genuine purchase by flashing the brand name, said the company.